Study on mechanism of interaction of nociceptin and opioids binding with opioid receptor-like 1 receptor

Acta Pharmacologica Sinica

Volumn 21, Issue 6, 2000, Pages 536-546

  Huang, Xiao Qin ^a   Jiang, Hua Liang ^a   Luo, Xiao Min ^a   Chen, Kai Xian ^a   Zhu, You Cheng ^a   Ji, Ru Yun ^a   Cao, Yang ^b  

^a SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

^b SOOCHOW UNIVERSITY   (China)

Author keywords

Binding energy; Etorphine; Lofentanyl; Molecular docking; Nociceptin; ORL1 receptor

Indexed keywords

ETORPHINE; LOFENTANIL; NOCICEPTIN; OPIATE DERIVATIVE; OPIATE RECEPTOR;

ARTICLE; BINDING AFFINITY; DRUG CONFORMATION; DRUG MECHANISM; DRUG RECEPTOR BINDING; DRUG STRUCTURE; LIGAND BINDING; MOLECULAR DYNAMICS; MOLECULAR MODEL;

BINDING SITES; DRUG INTERACTIONS; ETORPHINE; FENTANYL; MODELS, MOLECULAR; MOLECULAR CONFORMATION; OPIOID PEPTIDES; RECEPTORS, OPIOID;

EID: 0034088011     PISSN: 02539756     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Mollercau C, Parmentier M, Mailleux P, Meunier JC. ORL1, a novel member of the opioid receptor family, cloning, functional expression and localization. FEBS Lett 1994; 341: 33-8.
2. Meunier JC, Mollereau C, Toll L, Parmentier M, Costentin J. Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor. Nature 1995; 377: 532-5.
3. Lapalu S, Moisand C, Butour JC, Mollereau C, Meunier JC. Different domains of the ORL1 and κ-opioid receptors are involved in recognition of nociceptin and dynorphin A. FEBS Lett 1998; 427; 296-300.
4. Ewing TJA, Kuntz ID. Dock; Version 4.0. California; University of California in San Diego (UCSD) ; 1998.
5. Reinscheid RK, Higelin J, Henningsen RA, Monsma JFJ, Civelli O. Structures that delineate orphanin FQ and dynorphin A pharmacological selectivities. J Biol Chem 1998; 273; 1490-5.
6. Stahle L, Wold S. Multivariate analysis and experimental design in biochemical research. Prog Med Chem 1988; 25: 292-37.